Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Date:8/6/2013

ng three doses of AVP-923 for the treatment of central neuropathic pain in multiple sclerosis. Top-line results from this study are expected in the fourth calendar quarter of 2013.
  • The company entered into an exclusive North American license agreement for the development and commercialization of a novel Breath Powered™ intranasal delivery system containing low-dose sumatriptan powder to treat acute migraine (AVP-825). If approved, this product would be the first and only fast-acting, dry-powder nasal delivery form of sumatriptan.
  • Other EventsAvanir announced that on August 6, 2013, the Company approved the grant of stock options to new employees to purchase a total of 60,800 shares of common stock in the aggregate. The stock options were granted as inducements material to the new employees entering into employment with Avanir, as permitted under NASDAQ Listing Rule 5635(c)(4).

    Avanir granted to 12 new employees an option to purchase shares of Avanir's common stock with an exercise price equal the closing price per share of Avanir's common stock as reported by NASDAQ on August 6, 2013, the date of grant. Each of the options will vest with respect to one-quarter of the underlying shares on the first anniversary of the grant date and then with respect to the remaining shares quarterly thereafter over the following three years, assuming in each case the employee remains continuously employed by Avanir.

    Note to Investors: As previously announced, Avanir will hold a conference call to discuss fiscal 2013 third quarter financial results today, August 6, 2013, beginning at 1:30 p.m. Pacific Time. You can listen to this call by dialing 1-800 638-4817 for domestic callers or +1-617 614-3943 for international callers, and entering passcode 15448717. Those interested in listening to the conference call live via the internet may do so by visiting http://ir.avanir.com.

    About AVP-825
    AVP-825 is an
    '/>"/>

    SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Avanir Pharmaceuticals to Participate in Two Conferences in August
    2. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    3. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
    4. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
    5. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
    6. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
    7. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
    8. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
    9. AVANIR Pharmaceuticals To paticipate in two conferences in March
    10. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
    11. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... HONG KONG , August 28, 2015 ... Gero in collaboration with one of the leading academics ... Reis (current world record holder in life extension for ... new insights into biology of aging and age-related diseases, primarily, ... networks. The work has just been published as "Stability analysis ...
    (Date:8/28/2015)... and PITTSBURGH , Aug. 28, ... today announced that its shareholders have approved Mylan,s ... PRGO ; TASE) and the related issuance of ... extraordinary general meeting of shareholders held today. The ... at the extraordinary general meeting. In addition, the ...
    (Date:8/28/2015)... SAN FRANCISCO , August 28, 2015 ... is expected to reach USD 49.12 billion by 2020, ... 2020, according to a new report by Grand View ... an estimated CAGR of 49.7% from 2014 to 2020. ... Growing aging population along with rising incidences of ...
    Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
    (Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... ... has joined the company as the new Global Communications Director for InHealth Media. ... relations experience having spent the last 16 years doing on-air television, producing shows, ...
    (Date:8/30/2015)... ... August 30, 2015 , ... SonaCare ... for the treatment of prostate cancer, has announced the roll-out of its newest ... treatment center in Puerto Vallarta, Mexico. , The Sonablate® technology currently in use ...
    (Date:8/29/2015)... ... August 29, 2015 , ... "I have been ... Place, N.Y. "I specialize in manual therapy, and my invention will provide headache ... used for additional muscle dysfunction throughout the body." , They developed THE RELIEVER ...
    (Date:8/29/2015)... , ... August 29, 2015 , ... Next weekend is ... summer (which astronomically, officially ends on September 22nd this year). For IT security personnel, ... hangovers linger on which could prove far more costly than a simple headache. , ...
    (Date:8/29/2015)... TX (PRWEB) , ... August 29, 2015 , ... ... allows the company to freely market and sell Arterosil and Arterosil HP, and ... Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United ...
    Breaking Medicine News(10 mins):Health News:InHealth Media Appoints New Global Communications Director 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
    ... April 25 The United States,Agency for International ... Sur,Eau, a safe-water solution that reduces the risk ... prevents waterborne,diseases. The chlorine solution can be added ... protect people -- principally young children and,people living ...
    ... SAN DIEGO, April 25 SynergEyes, Inc., of ... designed for people,who need further vision correction after ... designed for patients who,have experienced some type of ... Every year, millions of people undergo LASIK ...
    ... as New Vice ... President, WASHINGTON, ... has joined the nonprofit Altarum Institute,as Vice President and Director of its ... to lead our Community Health,Systems Group, I hoped to find an individual ...
    ... by TV Game Show Host Spark Controversy, LOS ... of,the television game show "The Price Is Right," recently ... non-profit group formed to,support responsible dog ownership. The group ... that went into effect this month in Los,Angeles County ...
    ... 25 North Carolina-based Oaks,Development Group announced ... 25097 Olympia Avenue, in Punta Gorda, Florida. ... located near,Charlotte Regional Medical Center and currently ... being converted to Oaks, unique,tenant-ownership model., ...
    ... DAR ES SALAAM, Tanzania, April 25 Today is a,great ... to remember and a day to,celebrate. We celebrate because of ... deaths, announced today by the United,Nations Secretary General His Excellency ... if this initiative is implemented to the,letter, millions of lives ...
    Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2Health News:Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute 2Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:Oaks Development Group Acquires Medical Office Building in Punta Gorda, Florida 2Health News:Statement by H.E. Jakaya Mrisho Kikwete, President of the United Republic of Tanzania, and Chairman of the African Union, in Response to UN-SG Call to Action on Malaria 2
    Forceps, pointed, short jaws, suitable for epilation....
    1 mm x 6 mm oval hole....
    Bayonet forceps....
    Gerald bayonet forceps. Insulated....
    Medicine Products: